Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

CRISPR-engineered T cells in patients with refractory cancer.

Stadtmauer EA, Fraietta JA, Davis MM, Cohen AD, Weber KL, Lancaster E, Mangan PA, Kulikovskaya I, Gupta M, Chen F, Tian L, Gonzalez VE, Xu J, Jung IY, Melenhorst JJ, Plesa G, Shea J, Matlawski T, Cervini A, Gaymon AL, Desjardins S, Lamontagne A, Salas-Mckee J, Fesnak A, Siegel DL, Levine BL, Jadlowsky JK, Young RM, Chew A, Hwang WT, Hexner EO, Carreno BM, Nobles CL, Bushman FD, Parker KR, Qi Y, Satpathy AT, Chang HY, Zhao Y, Lacey SF, June CH.

Science. 2020 Feb 6. pii: eaba7365. doi: 10.1126/science.aba7365. [Epub ahead of print]

PMID:
32029687
2.

Adopting best practices in post-operative analgesia prescribing in a safety-net hospital: Residents as a conduit to change.

Bongiovanni T, Hansen K, Lancaster E, O'Sullivan P, Hirose K, Wick E.

Am J Surg. 2020 Feb;219(2):299-303. doi: 10.1016/j.amjsurg.2019.12.023. Epub 2019 Dec 21.

PMID:
31928779
3.

Variability in Opioid-Prescribing Patterns in Endocrine Surgery and Discordance With Patient Use.

Lancaster E, Inglis-Arkell C, Hirose K, Seib CD, Wick E, Sosa JA, Duh QY.

JAMA Surg. 2019 Aug 14. doi: 10.1001/jamasurg.2019.2518. [Epub ahead of print] No abstract available.

PMID:
31411647
4.

Description and Impact of a Comprehensive Multispecialty Multidisciplinary Intervention to Decrease Opioid Prescribing in Surgery.

Kaafarani HMA, Eid AI, Antonelli DM, Chang DC, Elsharkawy AE, Elahad JA, Lancaster EA, Schulz JT, Melnitchouk SI, Kastrinakis WV, Hutter MM, Masiakos PT, Colwell AS, Wright CD, Lillemoe KD.

Ann Surg. 2019 Sep;270(3):452-462. doi: 10.1097/SLA.0000000000003462.

PMID:
31356279
5.

An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models.

Dalmau J, Armangué T, Planagumà J, Radosevic M, Mannara F, Leypoldt F, Geis C, Lancaster E, Titulaer MJ, Rosenfeld MR, Graus F.

Lancet Neurol. 2019 Nov;18(11):1045-1057. doi: 10.1016/S1474-4422(19)30244-3. Epub 2019 Jul 17. Review.

PMID:
31326280
6.

A case series of PD-1 inhibitor-associated paraneoplastic neurologic syndromes.

Gill A, Perez MA, Perrone CM, Bae CJ, Pruitt AA, Lancaster E.

J Neuroimmunol. 2019 Sep 15;334:576980. doi: 10.1016/j.jneuroim.2019.576980. Epub 2019 Jun 5.

PMID:
31195181
7.

Residents as Key Effectors of Change in Improving Opioid Prescribing Behavior.

Lancaster E, Bongiovanni T, Lin J, Croci R, Wick E, Hirose K.

J Surg Educ. 2019 Nov - Dec;76(6):e167-e172. doi: 10.1016/j.jsurg.2019.05.016. Epub 2019 May 31.

PMID:
31155453
8.

Encephalitis, severe seizures, and multifocal brain lesions: Recognizing autoimmunity to the GABAA receptor.

Lancaster E.

Neurol Neuroimmunol Neuroinflamm. 2019 Apr 4;6(3):e554. doi: 10.1212/NXI.0000000000000554. eCollection 2019 May. No abstract available.

9.

Safety of EndoAnchors in real-world use: A report from the Manufacturer and User Facility Device Experience database.

Masoomi R, Lancaster E, Robinson A, Hacker E, Krajcer Z, Gupta K.

Vascular. 2019 Oct;27(5):495-499. doi: 10.1177/1708538119844041. Epub 2019 Apr 16. No abstract available.

10.

DNA methylation studies of depression with onset in the peripartum: A critical systematic review.

Braun SE, Lapato D, Brown RE, Lancaster E, York TP, Amstadter AB, Kinser PA.

Neurosci Biobehav Rev. 2019 Jul;102:106-122. doi: 10.1016/j.neubiorev.2019.04.005. Epub 2019 Apr 11. Review.

PMID:
30981737
11.

ADAM23 is a negative regulator of Kv1.1/Kv1.4 potassium currents.

Lancaster E, Burnor E, Zhang J, Lancaster E.

Neurosci Lett. 2019 Jun 21;704:159-163. doi: 10.1016/j.neulet.2019.04.012. Epub 2019 Apr 6.

PMID:
30965109
12.

Applications of Next-Generation Sequencing in Neoantigen Prediction and Cancer Vaccine Development.

Lancaster EM, Jablons D, Kratz JR.

Genet Test Mol Biomarkers. 2020 Feb;24(2):59-66. doi: 10.1089/gtmb.2018.0211. Epub 2019 Mar 22.

PMID:
30907630
13.

B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma.

Cohen AD, Garfall AL, Stadtmauer EA, Melenhorst JJ, Lacey SF, Lancaster E, Vogl DT, Weiss BM, Dengel K, Nelson A, Plesa G, Chen F, Davis MM, Hwang WT, Young RM, Brogdon JL, Isaacs R, Pruteanu-Malinici I, Siegel DL, Levine BL, June CH, Milone MC.

J Clin Invest. 2019 Mar 21;129(6):2210-2221. doi: 10.1172/JCI126397.

14.

Anti-MOG encephalitis mimicking small vessel CNS vasculitis.

Patterson K, Iglesias E, Nasrallah M, González-Álvarez V, Suñol M, Anton J, Saiz A, Lancaster E, Armangue T.

Neurol Neuroimmunol Neuroinflamm. 2019 Feb 1;6(2):e538. doi: 10.1212/NXI.0000000000000538. eCollection 2019 Mar.

15.

A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis.

Balu R, McCracken L, Lancaster E, Graus F, Dalmau J, Titulaer MJ.

Neurology. 2019 Jan 15;92(3):e244-e252. doi: 10.1212/WNL.0000000000006783. Epub 2018 Dec 21.

16.

AAV-Mediated Progranulin Delivery to a Mouse Model of Progranulin Deficiency Causes T Cell-Mediated Toxicity.

Amado DA, Rieders JM, Diatta F, Hernandez-Con P, Singer A, Mak JT, Zhang J, Lancaster E, Davidson BL, Chen-Plotkin AS.

Mol Ther. 2019 Feb 6;27(2):465-478. doi: 10.1016/j.ymthe.2018.11.013. Epub 2018 Nov 17.

17.

Gain of Function for the SCN1A/hNav1.1-L1670W Mutation Responsible for Familial Hemiplegic Migraine.

Dhifallah S, Lancaster E, Merrill S, Leroudier N, Mantegazza M, Cestèle S.

Front Mol Neurosci. 2018 Jul 9;11:232. doi: 10.3389/fnmol.2018.00232. eCollection 2018.

18.

Anti-NMDAR encephalitis in a patient with Crohn disease receiving adalimumab.

Noble GP, Lancaster E.

Neurol Neuroimmunol Neuroinflamm. 2018 Jul 2;5(5):e476. doi: 10.1212/NXI.0000000000000476. eCollection 2018 Sep. No abstract available.

19.

Isotype-Switched Autoantibodies Are Necessary To Facilitate Central Nervous System Autoimmune Disease in Aicda-/- and Ung-/- Mice.

Galicia G, Lee DSW, Ramaglia V, Ward LA, Yam JY, Leung LYT, Li R, Handy M, Zhang J, Drohomyrecky PC, Lancaster E, Bar-Or A, Martin A, Gommerman JL.

J Immunol. 2018 Aug 15;201(4):1119-1130. doi: 10.4049/jimmunol.1700729. Epub 2018 Jul 6.

20.

Myelinated axons fail to develop properly in a genetically authentic mouse model of Charcot-Marie-Tooth disease type 2E.

Lancaster E, Li J, Hanania T, Liem R, Scheideler MA, Scherer SS.

Exp Neurol. 2018 Oct;308:13-25. doi: 10.1016/j.expneurol.2018.06.010. Epub 2018 Jun 22.

PMID:
29940160
21.

Strategies to Reduce the Euthanasia of Impounded Dogs and Cats Used by Councils in Victoria, Australia.

Rand J, Lancaster E, Inwood G, Cluderay C, Marston L.

Animals (Basel). 2018 Jun 21;8(7). pii: E100. doi: 10.3390/ani8070100.

22.

Are collegiate athletes as healthy as we think they are?

Geller KS, Lancaster E, Hill C, Bettinger S.

Transl Behav Med. 2019 Jan 1;9(1):135-138. doi: 10.1093/tbm/iby039.

PMID:
29669136
23.

Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia.

Patterson KR, Dalmau J, Lancaster E.

Ann Neurol. 2018 Jan;83(1):40-51. doi: 10.1002/ana.25120. Epub 2018 Jan 10.

24.

Paraneoplastic Disorders.

Lancaster E.

Continuum (Minneap Minn). 2017 Dec;23(6, Neuro-oncology):1653-1679. doi: 10.1212/CON.0000000000000542.

PMID:
29200116
25.

Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies.

Burnor E, Yang L, Zhou H, Patterson KR, Quinn C, Reilly MM, Rossor AM, Scherer SS, Lancaster E.

Neurology. 2018 Jan 2;90(1):e31-e38. doi: 10.1212/WNL.0000000000004773. Epub 2017 Nov 29.

26.

Improving the antibody-based evaluation of autoimmune encephalitis.

McCracken L, Zhang J, Greene M, Crivaro A, Gonzalez J, Kamoun M, Lancaster E.

Neurol Neuroimmunol Neuroinflamm. 2017 Oct 11;4(6):e404. doi: 10.1212/NXI.0000000000000404. eCollection 2017 Nov.

27.

CNS syndromes associated with antibodies against metabotropic receptors.

Lancaster E.

Curr Opin Neurol. 2017 Jun;30(3):354-360. doi: 10.1097/WCO.0000000000000448. Review.

PMID:
28306571
28.

Serum neuronal cell-surface antibodies in first-episode psychosis.

Leypoldt F, de Witte L, Lancaster E, Titulaer MJ.

Lancet Psychiatry. 2017 Mar;4(3):186-187. doi: 10.1016/S2215-0366(17)30043-3. No abstract available.

PMID:
28236946
29.

Delta/Notch-Like EGF-Related Receptor (DNER) Is Not a Notch Ligand.

Greene M, Lai Y, Pajcini K, Bailis W, Pear WS, Lancaster E.

PLoS One. 2016 Sep 13;11(9):e0161157. doi: 10.1371/journal.pone.0161157. eCollection 2016.

30.

Anti-LGI1-associated cognitive impairment: Presentation and long-term outcome.

Ariño H, Armangué T, Petit-Pedrol M, Sabater L, Martinez-Hernandez E, Hara M, Lancaster E, Saiz A, Dalmau J, Graus F.

Neurology. 2016 Aug 23;87(8):759-65. doi: 10.1212/WNL.0000000000003009. Epub 2016 Jul 27.

31.

The clinical spectrum of Caspr2 antibody-associated disease.

van Sonderen A, Ariño H, Petit-Pedrol M, Leypoldt F, Körtvélyessy P, Wandinger KP, Lancaster E, Wirtz PW, Schreurs MW, Sillevis Smitt PA, Graus F, Dalmau J, Titulaer MJ.

Neurology. 2016 Aug 2;87(5):521-8. doi: 10.1212/WNL.0000000000002917. Epub 2016 Jul 1.

32.

Modeling Interventions in the Owned Cat Population to Decrease Numbers, Knox County, TN.

Lancaster EP, Lenhart S, Ojogbo EJ, Rekant SI, Scott JR, Weimer H, New JC Jr.

J Appl Anim Welf Sci. 2016 Oct-Dec;19(4):396-407. doi: 10.1080/10888705.2016.1176923. Epub 2016 May 6.

PMID:
27152694
33.

Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder.

Martinez-Hernandez E, Ariño H, McKeon A, Iizuka T, Titulaer MJ, Simabukuro MM, Lancaster E, Petit-Pedrol M, Planagumà J, Blanco Y, Harvey RJ, Saiz A, Graus F, Dalmau J.

JAMA Neurol. 2016 Jun 1;73(6):714-20. doi: 10.1001/jamaneurol.2016.0133.

34.

Reck enables cerebrovascular development by promoting canonical Wnt signaling.

Ulrich F, Carretero-Ortega J, Menéndez J, Narvaez C, Sun B, Lancaster E, Pershad V, Trzaska S, Véliz E, Kamei M, Prendergast A, Kidd KR, Shaw KM, Castranova DA, Pham VN, Lo BD, Martin BL, Raible DW, Weinstein BM, Torres-Vázquez J.

Development. 2016 Mar 15;143(6):1055. doi: 10.1242/dev.136507. No abstract available.

35.

A clinical approach to diagnosis of autoimmune encephalitis.

Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Prüss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostásy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J.

Lancet Neurol. 2016 Apr;15(4):391-404. doi: 10.1016/S1474-4422(15)00401-9. Epub 2016 Feb 20. Review.

36.

Subtype-specific therapy for autoimmune neuropathies?

Lancaster E, Scherer SS.

Neurol Neuroimmunol Neuroinflamm. 2015 Sep 24;2(5):e152. doi: 10.1212/NXI.0000000000000152. eCollection 2015 Oct. No abstract available.

37.

The Diagnosis and Treatment of Autoimmune Encephalitis.

Lancaster E.

J Clin Neurol. 2016 Jan;12(1):1-13. doi: 10.3988/jcn.2016.12.1.1. Review.

38.

Reck enables cerebrovascular development by promoting canonical Wnt signaling.

Ulrich F, Carretero-Ortega J, Menéndez J, Narvaez C, Sun B, Lancaster E, Pershad V, Trzaska S, Véliz E, Kamei M, Prendergast A, Kidd KR, Shaw KM, Castranova DA, Pham VN, Lo BD, Martin BL, Raible DW, Weinstein BM, Torres-Vázquez J.

Development. 2016 Jan 1;143(1):147-59. doi: 10.1242/dev.123059. Epub 2015 Dec 10. Erratum in: Development. 2016 Mar 15;143(6):1055.

39.

Problems Associated with the Microchip Data of Stray Dogs and Cats Entering RSPCA Queensland Shelters.

Lancaster E, Rand J, Collecott S, Paterson M.

Animals (Basel). 2015 May 13;5(2):332-48. doi: 10.3390/ani5020332.

40.

A Targeted Swallow Screen for the Detection of Postoperative Dysphagia.

Gee E, Lancaster E, Meltzer J, Mendelsohn AH, Benharash P.

Am Surg. 2015 Oct;81(10):979-82.

PMID:
26463293
41.

Caspr2 autoantibodies target multiple epitopes.

Olsen AL, Lai Y, Dalmau J, Scherer SS, Lancaster E.

Neurol Neuroimmunol Neuroinflamm. 2015 Jul 2;2(4):e127. doi: 10.1212/NXI.0000000000000127. eCollection 2015 Aug.

42.

Diagnosing Encephalitis, Not Otherwise Specified.

Wang ZL, Lancaster E, Yang L.

JAMA Neurol. 2015 Jun;72(6):725. doi: 10.1001/jamaneurol.2015.0542. No abstract available.

PMID:
26053445
43.

Diagnostic Value and Safety of Brain Biopsy in Patients With Cryptogenic Neurological Disease: A Systematic Review and Meta-analysis of 831 Cases.

Bai HX, Zou Y, Lee AM, Lancaster E, Yang L.

Neurosurgery. 2015 Aug;77(2):283-95; discussion 295. doi: 10.1227/NEU.0000000000000756. Review.

PMID:
25856111
44.

Paraneoplastic disorders.

Lancaster E.

Continuum (Minneap Minn). 2015 Apr;21(2 Neuro-oncology):452-75. doi: 10.1212/01.CON.0000464180.89580.88. Review.

45.

Assessing the incidence of anti-NMDAR encephalitis.

Greene M, Lancaster E.

Arch Dis Child. 2015 Jun;100(6):512-3. doi: 10.1136/archdischild-2014-307978. Epub 2015 Mar 25. No abstract available.

46.

Acetaminophen hepatotoxicity: an updated review.

Lancaster EM, Hiatt JR, Zarrinpar A.

Arch Toxicol. 2015 Feb;89(2):193-9. doi: 10.1007/s00204-014-1432-2. Epub 2014 Dec 24. Review.

47.

Paraneoplastic disorders in thymoma patients.

Evoli A, Lancaster E.

J Thorac Oncol. 2014 Sep;9(9 Suppl 2):S143-7. doi: 10.1097/JTO.0000000000000300. Review.

48.

Paraneoplastic cerebellar degeneration associated with noncutaneous Merkel cell carcinoma.

Zhang C, Emery L, Lancaster E.

Neurol Neuroimmunol Neuroinflamm. 2014 Jul 3;1(2):e17. doi: 10.1212/NXI.0000000000000017. eCollection 2014 Aug. No abstract available.

49.

Immunoglobulin G antibodies to the N-Methyl-D-aspartate receptor are distinct from immunoglobulin A and immunoglobulin M responses.

Lancaster E, Leypoldt F, Titulaer MJ, Honnorat J, Waters PJ, Reindl M, Höftberger R.

Ann Neurol. 2015 Jan;77(1):183. doi: 10.1002/ana.24233. Epub 2014 Dec 4. No abstract available.

50.

Therapeutic plasma exchange and immunosuppressive therapy in a patient with anti-GAD antibody-related epilepsy: quantification of the antibody response.

Farooqi MS, Lai Y, Lancaster E, Schmitt SE, Sachais BS.

J Clin Apher. 2015 Feb;30(1):8-14. doi: 10.1002/jca.21342. Epub 2014 Jun 25.

PMID:
24961613

Supplemental Content

Loading ...
Support Center